Stich, M., Ganß, L., Puschhof, J., Prigge, E., Reuschenbach, M., Gutiérrez Solis, A. L., & Knebel Doeberitz, M. v. (2017). 5-aza-2’-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells. OncoTarget, 8(32), . https://doi.org/10.18632/oncotarget.10631
Chicago-Zitierstil (17. Ausg.)Stich, Maximilian, Lennard Ganß, Jens Puschhof, Elena-Sophie Prigge, Miriam Reuschenbach, Ana Ligia Gutiérrez Solis, und Magnus von Knebel Doeberitz. "5-aza-2’-deoxycytidine (DAC) Treatment Downregulates the HPV E6 and E7 Oncogene Expression and Blocks Neoplastic Growth of HPV-associated Cancer Cells." OncoTarget 8, no. 32 (2017). https://doi.org/10.18632/oncotarget.10631.
MLA-Zitierstil (9. Ausg.)Stich, Maximilian, et al. "5-aza-2’-deoxycytidine (DAC) Treatment Downregulates the HPV E6 and E7 Oncogene Expression and Blocks Neoplastic Growth of HPV-associated Cancer Cells." OncoTarget, vol. 8, no. 32, 2017, https://doi.org/10.18632/oncotarget.10631.